Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020
Western Pacific Surveillance and Response Journal · 27.07.2023 · 14 (3) · 45-57
DOI: 10.5365/wpsar.2023.14.3.976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Western Pacific Surveillance and Response Journal, online erschienen am 27.07.2023. Verfasst von Fukushi Morishita und 7 weiteren Autor:innen. Beteiligte Einrichtung: End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines. Hauptthemen laut MEDLINE: Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Objective
This paper provides an overview of financing for tuberculosis (TB) prevention, diagnostic and treatment services in the World Health Organization (WHO) Western Pacific Region during 2005–2020.
Methods
This analysis uses the WHO global TB finance database to describe TB funding during 2005–2020 in 18 low- and middle-income countries (LMICs) in the Western Pacific Region, with additional country-level data and analysis for seven priority countries: Cambodia, China, the Lao People’s Democratic Republic, Mongolia, Papua New Guinea, the Philippines and Viet Nam.
Results
Funding for the provision of TB prevention, diagnostic and treatment services in the 18 LMICs tripled from US$ 358 million in 2005 to US$ 1061 million in 2020, driven largely by increases in domestic funding, which rose from US$ 325 million to US$ 939 million over the same period. In the seven priority countries, TB investments also tripled, from US$ 340 million in 2005 to US$ 1020 million in 2020. China alone accounted for much of this growth, increasing its financing for TB programmes and services five-fold, from US$ 160 million to US$ 784 million. The latest country forecasts estimate that US$ 3.8 billion will be required to fight TB in the seven priority countries by 2025, which means that unless additional funding is mobilized, the funding gap will increase from US$ 326 million in 2020 to US$ 830 million by 2025.
Discussion
Increases in domestic funding over the past 15 years reflect a firm political commitment to ending TB. However, current funding levels do not meet the required needs to finance the national TB strategic plans in the priority countries. An urgent step-up of public financing efforts is required to reduce the burden of TB in the Western Pacific Region.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- End TB and Leprosy Unit, World Health Organization Regional Office for the Western Pacific, Manila, Philippines.
- Global TB Programme, World Health Organization, Geneva, Switzerland.
Förderung
- World Health Organization
Zitieren
APA
Morishita, F., Elsayed, H., Islam, T., Rahevar, K., Oh, K. H., Yanagawa, M., Floyd, K., & Baena, I. G. (2023). Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020. Western Pacific Surveillance and Response Journal, 14(3), 45-57. https://doi.org/10.5365/wpsar.2023.14.3.976
Vancouver
Morishita F, Elsayed H, Islam T, Rahevar K, Oh KH, Yanagawa M, et al. Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020. Western Pacific Surveillance and Response Journal. 2023;14(3):45-57. doi:10.5365/wpsar.2023.14.3.976
BibTeX
@article{Morishita2023,
author = {Morishita, Fukushi and Elsayed, Hend and Islam, Tauhid and Rahevar, Kalpeshsinh and Oh, Kyung Hyun and Yanagawa, Manami and Floyd, Katherine and Baena, Inés Garcia},
title = {Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020},
journal = {Western Pacific Surveillance and Response Journal},
year = {2023},
volume = {14},
number = {3},
pages = {45--57},
doi = {10.5365/wpsar.2023.14.3.976}
}
EUVIMED